|
Free
As biopharma shows, strong order books don't justify rich multiples unless backed by sustainable demand, margins, and cash conversion.
|
Free
As the Fed pauses and balance-sheet support fades, AI capex faces a more contested, data-dependent policy era.
|
Free
Unit costs drop 1,200x yet aggregate spending rises as inference becomes recurring infrastructure layer
|
Free
How memory, supply chains, and valuation expectations shape NVDA's investment case amid uneven technical signals.
|
Free
Five-year supply contracts and AI demand improve visibility, but the same commitments could concentrate risk and amplify a future downturn.
|
Free
NVIDIA's opportunity is thematic: demand for high-performance compute, networking, and secure systems spans AI inference and digital finance.
|
Free
A comprehensive analysis of Uber's record user growth, triple-engine bookings, and why owning demand beats owning vehicles.
|
Free
How debt-funded capacity, negative cash flow, and OpenAI concentration shape Oracle's path from RPO to revenue.
|
Free
Pressure selling in NVDA-linked futures and weak spot volumes argue for tactical caution, not a broken AI thesis